Corcept Therapeutics Stock News & Updates
[WKN: 529882 | Symbol: CORT]Corcept Therapeutics: Forecast Sensation & Lifyorli Fueling Accumulation
Corcept Therapeutics: New All-Time High Due to Strong Growth in Cortisol Medications
Corcept Therapeutics researches and develops medications that regulate the effects of the stress hormone...
The Tech Sector Celebrates the Comeback of the AI Trade, While Chip Giants Rebound After the AI Sell-Off – Microsoft Surpasses the $100 Billion Mark With Its Azure Cloud for the First Time, and Samsung Multiplies Its Chip Earnings by 250 Times – But the Bond Markets Rebel Against Fed Chair Kevin Warsh and Push the 30-Year US Yield to Its Highest Level Since 2007, While the DAX Holds Just Above 25,500 Points
USA & MACRO-ENVIRONMENT Wall Street stages a powerful comeback …, after brave bargain hunters...
Stocks in Action USA: Lam Research, Quanta Services and Corcept Therapeutics.
Lam Research (LRCX) Excites with Record Quarter – AI Demand Drives Growth to New Heights! Lam Research has...
Analysts' Top 5 Price Targets of May 29, 2026
Ouster Inc. [US68989M2026]: Roth MKM starts coverage with a "Buy" rating and a target of 75 USD (77%...
TOP-5 Price Targets of Analysts on May 13, 2026
Siemens Energy [DE000ENER6Y0] JPMorgan reiterates Overweight rating and raises the price target from...
Corcept Therapeutics: FDA Approval as a Gamechanger - Oncology Breakthrough as a Price Driver
FDA Approval as a Historic Milestone For Corcept Therapeutics (CORT) , late March 2026 marks a pivotal...
Corcept Therapeutics in our Pivotal Point Check: Breakthrough in Cancer Research - ROSELLA Study Success Catapults Stock up Over 100%!
Ovarian cancer is the fifth leading cause of cancer-related death among women. The ROSELLA study...
Stocks in Action USA: Garmin, Rocket and Corcept.
Garmin (GRMN) - The wearable specialist focuses on AI in the fitness sector: New subscription platform...
Darvas Screening: DraftKings, Carvana, Corcept Therapeutics, Innodata
DraftKings DraftKings (NASDAQ: DKNG) is a digital sports entertainment and gaming company that offers...
Corcept Therapeutics: Rising Company in the Treatment of Cushing's Syndrome
Corcept Therapeutics is a specialist in cortisol modulation and controls the excess production of the...
Corcept Therapeutics (CORT): Canaccord sees 111% price potential - Phase III data from the ROSELLA study could impress
Corcept Therapeutics Inc. (CORT) is focused on the development of drugs that modulate the effects of...